Sputnik V

Products Sputnik V is a Covid-19 vaccine developed in Russia and the first vaccine from this group to be registered on August 11, 2020 (Gamaleya National Center of Epidemiology and Microbiology). The name is derived from the Sputnik satellite, which was the first satellite placed in Earth orbit by the Soviet Union in 1957. Sputnik … Sputnik V

COVID-19

Symptoms Symptoms of Covid-19 include (selection): Fever Cough (irritating cough or with sputum) Respiratory disorders, shortness of breath, shortness of breath. Feeling sick, fatigue Cold symptoms: runny nose, stuffy nose, sore throat. Pain in the limbs, muscle and joint pain. Gastrointestinal complaints: Diarrhea, nausea, vomiting, abdominal pain. Nervous system: impairment of the sense of smell … COVID-19

APN01 (Recombinant ACE2)

Products APN01 is in clinical development at Apeiron Biologics. Structure and properties APN01 is a recombinant, soluble, and human angiotensin-converting enzyme 2 (ACE2). Effects APN01 functions as a false receptor for the coronavirus SARS-CoV-2, the causative agent of the viral disease Covid-19. SARS-CoV-2 uses ACE2 for attachment and entry into host cells. APN01 is a … APN01 (Recombinant ACE2)

AZD1222

Products AZD1222 has been in the registration phase in the EU and many countries since the beginning of October 2020 as part of a rolling review and is not yet commercially available. The vaccine was developed at Oxford University’s Jenner Institute, spin-off Vaccitech and AstraZeneca. Efficacy and safety are being evaluated in studies involving up … AZD1222

MRNA-1273

Products mRNA-1273 enters the market as a white dispersion in multidose containers. It was licensed in the EU on January 6, 2021, and in many countries on January 12, 2021. The vaccine has been studied in a clinical trial involving more than 30,000 participants. The unopened multi-dose vial can be stored at -15 °C to … MRNA-1273

COVID-19 Rapid Antigen Tests

Products Rapid antigen tests for the detection of SARS-CoV-2 are available as medical devices from various suppliers (e.g., Roche, Abbott) for use by health care professionals. They are not approved for self-testing by patients in many countries. The rapid tests can be performed, for example, in doctors’ offices, hospitals, test centers, laboratories and pharmacies with … COVID-19 Rapid Antigen Tests

COVID-19 Vaccines

Products Covid-19 vaccines are in the development and approval phase and are already available in some countries. In many countries, BNT162b2 was the first agent approved on December 19, 2020. mRNA-1273 was approved in the EU on January 6, 2021, and in many countries on January 12, 2021. The first approval will be in Russia … COVID-19 Vaccines

Glycerol Alcohol 80%

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.